CHA2DS2-VASc评分在不同种族房颤患者中的卒中预测
结果显示黑人的发病率较高,但评分的预测能力在三个种族中相当,且加入种族/族裔信息未改善预测能力。
要点
- 在黑人、西班牙裔和白人房颤患者中,CHA2DS2-VASc评分对缺血性卒中或TIA的预测能力相当。
- 黑人患者的缺血性卒中或TIA发病率高于西班牙裔和白人。
- 将种族/族裔加入CHA2DS2-VASc评分并未改善其预测能力。
核心结论
- CHA2DS2-VASc评分对房颤患者缺血性卒中或TIA的预测能力在白人、黑人和西班牙裔中相当,因此可在后两组中使用。
- 将种族/族裔加入CHA2DS2-VASc评分并未改善其预测能力。
研究设计与样本
- 研究使用Optum Clinformatics大型行政索赔数据库,分析2009至2015年间纳入商业和Medicare Advantage健康计划的房颤患者。
主要发现
- 平均随访22个月,共发生6202例缺血性卒中或TIA事件。
- 黑人、西班牙裔和白人的缺血性卒中或TIA发病率分别为每100人年1.65、1.40和1.22例。
- 发病率随CHA2DS2-VASc评分升高而增加,且无种族/族裔差异(交互作用P=0.17)。
- CHA2DS2-VASc评分的C统计量为0.679(95%CI 0.670-0.686),加入种族/族裔后为0.679(95%CI 0.671-0.688)。
- 加入种族/族裔后,分类净重分类改善为-0.045(95%CI -0.067至-0.025),连续净重分类改善为0.045(95%CI 0.025-0.068),相对综合判别改善为0.016(95%CI 0.014-0.018)。
临床怎么用
- CHA2DS2-VASc评分可用于黑人、西班牙裔和白人房颤患者的卒中风险预测。
- 无需在CHA2DS2-VASc评分中额外加入种族/族裔信息来改善预测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background and Purpose- Despite modest predictive ability for ischemic stroke (IS), the CHA2DS2-VASc score is widely used for stroke prediction in atrial fibrillation. Among patients with atrial fibrillation, we aimed to (1) compare the IS or transient ischemic attack (TIA) incidence by CHA2DS2-VASc in blacks and Hispanics versus whites; (2) compare predictive ability of CHA2DS2-VASc score for IS or TIA in blacks and Hispanics versus whites; and (3) determine improvement in predictive ability of CHA2DS2-VASc score from addition of race/ethnicity. Methods- Using data from Optum Clinformatics, a large administrative claims database, we analyzed patients with atrial fibrillation enrolled in commercial and Medicare Advantage health plans from 2009 to 2015. We computed IS or TIA incidence rates, improvement in C statistic, continuous and categorical net reclassification improvement, and relative integrated discrimination improvement from addition of race/ethnicity to CHA2DS2-VASc. Results- A total of 267 419 patients (mean age, 73.1 [SD, 12.3] years; 46.6% women; 84.2% white, 8.5% black, 7.3% Hispanic) were studied. After a mean follow-up of 22 months, there were 6202 IS or TIA events. IS or TIA incidence rates were higher in blacks than Hispanics or whites (1.65, 1.40, and 1.22 cases per 100 person-years, respectively) and increased with higher CHA2DS2-VASc, with no race/ethnicity-based differences (P for interaction=0.17). The CHA2DS2-VASc and CHA2DS2-VASc+race/ethnicity C statistic (95% CI) were 0.679 (0.670-0.686) and 0.679 (0.671-0.688). The CHA2DS2-VASc C statistic in the 3 groups were comparable. With addition of race/ethnicity, the categorical net reclassification improvement, continuous net reclassification improvement, and relative integrated discrimination improvement were -0.045 (95% CI, -0.067 to -0.025), 0.045 (95% CI, 0.025-0.068), and 0.016 (95% CI, 0.014-0.018). Conclusions- The predictive ability of CHA2DS2-VASc for IS or TIA in atrial fibrillation is comparable among whites, blacks, and Hispanics; hence, it can be used in the latter 2 groups. Addition of race/ethnicity to the CHA2DS2-VASc does not improve its predictive ability.
引用
- Chen LY, Norby FL, Chamberlain AM, et al. CHA2DS2-VASc Score and Stroke Prediction in Atrial Fibrillation in Whites, Blacks, and Hispanics. Stroke. 2018. PMID: 30580712. doi:10.1161/STROKEAHA.118.021453
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。